A Multiprotein Supercomplex Controlling Oncogenic Signaling in Lymphoma

B cell receptor (BCR) signaling has emerged as a therapeutic target in B cell lymphomas, but inhibiting this pathway in diffuse large B cell lymphoma (DLBCL) has benefited only a subset of patients(1). Gene expression profiling identified two major DLBCL subtypes, known as germinal center (GC) B cel...

Descripción completa

Detalles Bibliográficos
Autores principales: Phelan, James D., Young, Ryan M., Webster, Daniel E., Roulland, Sandrine, Wright, George W., Kasbekar, Monica, Shaffer, Arthur L., Ceribelli, Michele, Wang, James Q., Schmitz, Roland, Nakagawa, Masao, Bachy, Emmanuel, Huang, Da Wei, Ji, Yanlong, Chen, Lu, Yang, Yandan, Zhao, Hong, Yu, Xin, Xu, Weihong, Palisoc, Maryknoll M., Valadez, Racquel R., Davies-Hill, Theresa, Wilson, Wyndham H., Chan, Wing C., Jaffe, Elaine S., Gascoyne, Randy D., Campo, Elias, Rosenwald, Andreas, Ott, German, Delabie, Jan, Rimsza, Lisa M., Rodriguez, Fausto J., Estephan, Fayez, Holdhoff, Matthias, Kruhlak, Michael J., Hewitt, Stephen M., Thomas, Craig J., Pittaluga, Stefania, Oellerich, Thomas, Staudt, Louis M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201842/
https://www.ncbi.nlm.nih.gov/pubmed/29925955
http://dx.doi.org/10.1038/s41586-018-0290-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201842/
https://www.ncbi.nlm.nih.gov/pubmed/29925955
http://dx.doi.org/10.1038/s41586-018-0290-0

Ejemplares similares